Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B

Dendritic cells (DC) play an important role in the induction of T‐cell responses. We hypothesize that the hampered antiviral T‐cell response in chronic hepatitis B patients is a result of impaired dendritic cell function. In this study, we compared the number, phenotype and functionality of two important blood precursor DC, myeloid DC (mDC) and plasmacytoid DC (pDC), of chronic hepatitis B patients with healthy volunteers. No differences in percentages of mDC and pDC in peripheral blood mononuclear cells were observed between chronic hepatitis B patients and healthy controls. The allostimulatory capacity of isolated and in vitro matured mDC, but not of pDC, was significantly decreased in patients compared to controls. Accordingly, a decreased percentage of mDC expressing CD80 and CD86 was observed after maturation, compared to controls. In addition, mDC of patients showed a reduced capacity to produce tumor necrosis factor α after a stimulus with synthetic double‐stranded RNA and interferon γ. Purified pDC from patients produced less interferon α, an important antiviral cytokine, in response to stimulation with Staphylococcus aureus Cowan strain I than pDC isolated from controls. In conclusion, mDC and pDC are functionally impaired in patients with chronic hepatitis B. This might be an important way by which hepatitis B virus evades an adequate immune response, leading to viral persistence and disease chronicity. (HEPATOLOGY 2004;40:738–746.)

[1]  D. Stolz,et al.  Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. , 2002, Clinical immunology.

[2]  H. Asada,et al.  Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. , 1997, The Journal of clinical investigation.

[3]  Y. Osugi,et al.  Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. , 2002, Blood.

[4]  L. Aarden,et al.  Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. , 1996, Journal of immunology.

[5]  Antonio Bertoletti,et al.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. , 2000 .

[6]  B. Gazzard,et al.  Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. , 2003, Blood.

[7]  F. Gheyas,et al.  Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.

[8]  A. McLellan,et al.  Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand‐dependent pathway , 1996, European journal of immunology.

[9]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[10]  W. Hop,et al.  Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment , 1999, Hepatology.

[11]  V. Soumelis,et al.  Dendritic cell lineage, plasticity and cross-regulation , 2001, Nature Immunology.

[12]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[13]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[14]  R. Steinman,et al.  Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. , 1994, Immunology.

[15]  A. Lanzavecchia,et al.  Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization , 2000, Nature Immunology.

[16]  D. Vergani,et al.  Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. , 1999, Gastroenterology.

[17]  D. Vergani,et al.  Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.

[18]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[19]  R. D. de Man,et al.  Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays , 2000, Journal of Clinical Microbiology.

[20]  R. Bontrop,et al.  Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment , 2003, Hepatology.

[21]  A. Dhillon,et al.  Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial , 2000, Gut.

[22]  M. Hussain,et al.  Induction of T‐helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus , 1995, Hepatology.

[23]  G. Trinchieri,et al.  Persistent Decreases in Blood Plasmacytoid Dendritic Cell Number and Function Despite Effective Highly Active Antiretroviral Therapy and Increased Blood Myeloid Dendritic Cells in HIV-Infected Individuals1 , 2002, The Journal of Immunology.

[24]  D. Vergani,et al.  The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection , 2000, The Journal of experimental medicine.

[25]  N. Hayashi,et al.  Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. , 1999, Journal of immunology.

[26]  E. Keeffe,et al.  Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. , 2001, Blood.

[27]  F. Zoulim,et al.  Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. , 2001, Gastroenterology.

[28]  J. Melnick,et al.  Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. , 1986, The Journal of infectious diseases.

[29]  Michael G. Katze,et al.  Viruses and interferon: a fight for supremacy , 2002, Nature Reviews Immunology.

[30]  M. Kohara,et al.  Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. , 2003, International journal of molecular medicine.

[31]  R. Steinman,et al.  The interaction of immunodeficiency viruses with dendritic cells. , 2003, Current topics in microbiology and immunology.

[32]  P. Fitzgerald-Bocarsly,et al.  Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. , 2001, Clinical immunology.

[33]  Y. Kooyk,et al.  DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. , 2003, Current topics in microbiology and immunology.

[34]  N. Kadowaki,et al.  Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity , 2000, The Journal of experimental medicine.

[35]  J. Ellwart,et al.  Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells1 , 2001, The Journal of Immunology.

[36]  C. Rabourdin-Combe,et al.  Measles Virus Suppresses Cell-mediated Immunity by Interfering with the Survival and Functions of Dendritic and T Cells , 1997, The Journal of experimental medicine.

[37]  H. Einsele,et al.  Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. , 2000, The Journal of general virology.

[38]  P. Kalinski,et al.  Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. , 1998, Journal of immunology.

[39]  J. McKenzie,et al.  Role of tumour necrosis factor-alpha in dendritic cell-mediated primary mixed leucocyte reactions. , 1995, Bone marrow transplantation.

[40]  G. Alexander,et al.  Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. , 1991, Journal of hepatology.

[41]  Y. C. Chen,et al.  State of hepatitis B virus DNA in leucocytes of hepatitis B patients , 1985, Journal of medical virology.

[42]  Virginia Pascual,et al.  Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. , 2003, Immunity.

[43]  S. Rose-John,et al.  Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin‐12 , 2002, Clinical and experimental immunology.